A detailed history of Andrew Hill Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Andrew Hill Investment Advisors, Inc. holds 1,767 shares of ABT stock, worth $204,795. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,767
Holding current value
$204,795
% of portfolio
0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$100.07 - $118.13 $176,823 - $208,735
1,767 New
1,767 $201,000
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $193,521 - $213,736
1,767 New
1,767 $200,000
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $169,889 - $207,169
-1,490 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $172,139 - $210,775
1,490 New
1,490 $209,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Andrew Hill Investment Advisors, Inc. Portfolio

Follow Andrew Hill Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andrew Hill Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andrew Hill Investment Advisors, Inc. with notifications on news.